TY - JOUR
T1 - Elucidating the association between depression, anxiety, and cognition in middle-aged adults
T2 - Application of dimensional and categorical approaches
AU - Perin, Stephanie
AU - Lai, Janice
AU - Pase, Matthew
AU - Bransby, Lisa
AU - Buckley, Rachel
AU - Yassi, Nawaf
AU - Pietrzak, Robert H.
AU - Maruff, Paul
AU - Lim, Yen Ying
N1 - Funding Information:
The Healthy Brain Project (healthybrainproject.org.au) is funded by the National Health and Medical Research Council (GNT1158384, GNT1147465, GNT1111603, GNT1105576, GNT1104273, GNT1158384, GNT1171816), the Alzheimer's Association (AARG-17–591424, AARG-18–591358, AARG-19–643133), the Dementia Australia Research Foundation, the Bethlehem Griffiths Research Foundation, the Yulgilbar Alzheimer's Research Program, the National Heart Foundation of Australia (102052), and the Charleston Conference for Alzheimer's Disease.
Funding Information:
L Bransby is supported by a Dementia Australia Research Foundation PhD Scholarship. MP Pase is supported by a Heart Foundation Future Leader Fellowship (GNT102052). RF Buckley is supported by a National Institutes of Health K99-R00 award (K99AG061238). YY Lim is supported by an NHMRC Career Development Fellowship (GNT1162645).
Publisher Copyright:
© 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Background: In older adults, depressive and anxiety symptoms are associated with dementia risk, and represent a manifestation of the dementia prodrome. Understanding how these symptoms are related to cognition in midlife may inform risk models of dementia. Methods: This study examined the relationship between depressive and anxiety symptoms, and cognition, in a sample (n= 2,657) of participants enrolled in the Healthy Brain Project. Depressive and Anxiety symptoms were assessed using the Depression Anxiety and Stress Scale, Hospital Anxiety and Depression Scale, and centre for Epidemiological Studies Depression Scale. Objective cognition was assessed using the Cogstate Brief Battery and subjective cognition assessed using the Alzheimer's disease Cooperative Study Cognitive Function Instrument. Results: Somatic- and panic-related anxiety symptoms were associated significantly with poorer attention; while tension- and panic-related anxiety were associated significantly with poorer memory. Having clinically meaningful anxiety or depressive symptoms was associated with increased subjective cognitive concerns (d=-0.37). This was further increased for those with clinically meaningful anxiety and depressive symptoms (d = -1.07). Limitations: This study reports cross-sectional data, and uses a sample enriched with individuals with a family history of dementia who are therefore at a higher risk of developing dementia compared to the general population. Additionally, biological markers such as cortisol, Aβ, and tau were unavailable. Conclusion: The results support the hypothesis that depressive and anxiety symptoms may increase risk of cognitive decline. Further, they suggest that using depression and anxiety as clinical markers may be helpful in identifying the earliest signs of cognitive decline.
AB - Background: In older adults, depressive and anxiety symptoms are associated with dementia risk, and represent a manifestation of the dementia prodrome. Understanding how these symptoms are related to cognition in midlife may inform risk models of dementia. Methods: This study examined the relationship between depressive and anxiety symptoms, and cognition, in a sample (n= 2,657) of participants enrolled in the Healthy Brain Project. Depressive and Anxiety symptoms were assessed using the Depression Anxiety and Stress Scale, Hospital Anxiety and Depression Scale, and centre for Epidemiological Studies Depression Scale. Objective cognition was assessed using the Cogstate Brief Battery and subjective cognition assessed using the Alzheimer's disease Cooperative Study Cognitive Function Instrument. Results: Somatic- and panic-related anxiety symptoms were associated significantly with poorer attention; while tension- and panic-related anxiety were associated significantly with poorer memory. Having clinically meaningful anxiety or depressive symptoms was associated with increased subjective cognitive concerns (d=-0.37). This was further increased for those with clinically meaningful anxiety and depressive symptoms (d = -1.07). Limitations: This study reports cross-sectional data, and uses a sample enriched with individuals with a family history of dementia who are therefore at a higher risk of developing dementia compared to the general population. Additionally, biological markers such as cortisol, Aβ, and tau were unavailable. Conclusion: The results support the hypothesis that depressive and anxiety symptoms may increase risk of cognitive decline. Further, they suggest that using depression and anxiety as clinical markers may be helpful in identifying the earliest signs of cognitive decline.
KW - Alzheimer's disease
KW - Anxiety
KW - Dementia risk reduction
KW - Depression
UR - http://www.scopus.com/inward/record.url?scp=85117201347&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2021.10.007
DO - 10.1016/j.jad.2021.10.007
M3 - Article
C2 - 34648818
AN - SCOPUS:85117201347
SN - 0165-0327
VL - 296
SP - 559
EP - 566
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -